Skip to main content
Mazen Noureddin, MD, Gastroenterology, Houston, TX, Cedars-Sinai Medical Center

MazenNoureddinMDMHSc

Gastroenterology Houston, TX

Hepatology & Liver Transplantation

Transplant Hepatologist, Houston Methodist Hospital, Director Houston Research Institute

Dr. Noureddin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Noureddin's full profile

Already have an account?

Education & Training

  • Duke School of Medicine
    Duke School of MedicineMHSc, Master's Health Sciences in Clinical Research, 2009 - 2018
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Gastroenterology, 2011 - 2013
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Transplant Hepatology, 2009 - 2011
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2005 - 2008
  • University of Aleppo Faculty of Medicine
    University of Aleppo Faculty of MedicineClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2007 - 2025
  • TX State Medical License
    TX State Medical License 2022 - 2025
  • VA State Medical License
    VA State Medical License 2008 - 2012
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Top Doctors Pasadena Magazine 2014-2018
  • Visionary in Health Care American Liver Foundation, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.  
    Noureddin M1,2, Vipani A3, Bresee C4, Todo T5, Kim IK5, Alkhouri N6, Setiawan VW7, Tran T8,3, Ayoub WS8,3, Lu SC8,3, Klein AS5, Sundaram V8,3, Nissen NN5., American Journal of Gastrenterology, 6/8/2018
  • NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications for Liver Transplant and Ethnic and Gender Variances  
    Tsuyoshi Todo, Walid S Ayoub, Naim Alkhouri, Nicholas N Nissen, Vinay Sundaram, Shelly C Lu, Mazen Noureddin, Aarshi Vipani, Tram Tran, Andrew S Klein, Nature

Press Mentions

  • Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress™ 2022
    Galectin Therapeutics Announces 2 Liver Cirrhosis Scientific Presentations at the EASL International Liver Congress™ 2022June 21st, 2022
  • Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.
    Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.January 26th, 2022
  • Early Identification of Fatty Liver Using Echosens FibroScan Potentially Gives Payers Five-Year Gross Savings of $10+ Million, Confirmed by Independent Study
    Early Identification of Fatty Liver Using Echosens FibroScan Potentially Gives Payers Five-Year Gross Savings of $10+ Million, Confirmed by Independent StudyDecember 6th, 2021
  • Join now to see all

Other Languages

  • Arabic, Farsi, Spanish

Hospital Affiliations